Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

PLoS Pathogens(2021)10.1371/journal.ppat.1009897Source: DataRank Database

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 78 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access78 citations

Download PDF

Cite:

Linked data & code

gen refseq uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 4.45)OA: goldTopics (79)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Wanbo Tai ORCID,Victoria K. Baxter ORCID,Juan Shi ORCID,Yushun Wan ORCID,Xiujuan Zhang ORCID

Live enrichment

PubMed:34492082 PMC:PMC8448314 OpenAlex:https://openalex.org/W3198305960

National Institutes of Health

Grant: R01AI139092

National Institutes of Health

Grant: R01AI089728

National Institutes of Health

Grant: R01 AI110700

National Institutes of Health

Grant: U01 AI149644

National Institutes of Health

Grant: R01AI157253

National Institutes of Health

Grant: K01OD026529

National Institutes of Health

Grant: T32AI007419

National Institutes of Health

Grant: T32AI007151

National Institutes of Health

Grant: 1U01AI149644-01

Respiratory Virus Vaccine and Adjuvant Exploration

National Institutes of Health

Grant: 5R01AI139092-04

Structure-based design of coronavirus subunit vaccines

National Institutes of Health

Grant: 5R01AI089728-07

Receptor recognition and cell entry of coronaviruses

National Institutes of Health

Grant: 5R01AI157253-05

Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross

National Institutes of Health

Grant: 1K01OD026529-01

Pathogenesis of and host response to chikungunya virus infection of the central nervous system

National Institutes of Health

Grant: 5T32AI007419-09

MOLECULAR BIOLOGY OF VIRAL DISEASES

National Institutes of Health

Grant: 1R01AI110700-01A1

Mechanisms of MERS-CoV Entry, Cross-species Transmission and Pathogenesis

National Institutes of Health

Grant: 5T32AI007151-42

Infectious Disease Pathogenesis Research Training Program

University of Minnesota

FWCI

4.45

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009897&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009897&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009897

journalhttps://doi.org/10.1371/journal.ppat.1009897

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34492082

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0301 basic medicine03 medical and health sciencesAngiotensin-Converting Enzyme 2AnimalsAntibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesDisease Models, AnimalDrug DesignFemaleHEK293 CellsHumansImmunogenicity, VaccineLungMiceMice, Inbred BALB CNanoparticlesProtein Domains

MeSH Terms

Immunogenicity, VaccineProtein DomainsAngiotensin-Converting Enzyme 2COVID-19COVID-19 VaccinesAnimalsAntibodies, ViralDisease Models, AnimalFemaleHumansLungMice, Inbred BALB CDrug DesignMiceNanoparticlesAntibodies, NeutralizingHEK293 Cells

Keywords

ImmunogenVirologyVirusNeutralizing antibodyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunityImmune systemVaccine efficacyAntibodyVirus-like particleCoronavirus disease 2019 (COVID-19)MedicineVaccinationRecombinant DNAImmunologyMonoclonal antibodyInfectious disease (medical specialty)Mice, Inbred BALB CCOVID-19 VaccinesQH301-705.5COVID-19RC581-607Antibodies, ViralAntibodies, NeutralizingDisease Models, AnimalMiceHEK293 CellsImmunogenicity, VaccineProtein DomainsDrug DesignAnimalsHumansNanoparticlesFemaleAngiotensin-Converting Enzyme 2Immunologic diseases. AllergyBiology (General)LungResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

FAIR Checklist

Authors (21)

Funding (17 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)